10-Year watch on Life-Saving aortic device
Disease control
Ongoing
This study is monitoring patients for 10 years after they receive a Thoraflex Hybrid device to treat serious conditions like aortic aneurysms and dissections. The goal is to see how safe and effective the device is, especially when it's extended with another stent called RelayPro…
Sponsor: Vascutek Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC